Visalytics
Visalytics
approved EB-2 (NIW)

House Officer

Medicine · Greece · 2025-11-13

Processing Time
37 days
Decision Date
2025-11-13
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to conduct clinical and translational research focused on identifying predictors of myocardial recovery in patients with advanced heart failure supported by mechanical circulatory devices. The work aims to evaluate the durability of recovery following device explant and develop clinical strategies to reduce mortality and hospital readmissions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research directly contributes to clinical strategies that reduce mortality and healthcare costs for heart failure, a leading cause of death in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 24 publications and 323 citations, including highly-cited papers in top journals, demonstrates their influence and capability in the field.

3 On Balance, Beneficial to Waive Job Offer/Labor Cert Met

USCIS determined that the petitioner's potential for groundbreaking advances in cardiovascular outcomes makes a waiver of the labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. degree and a record of 24 peer-reviewed journal articles which garnered 323 citations. Evidence showed several publications ranked in the top 1%, 10%, and 20% of most-cited works in clinical medicine, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions

Similar Cases

Assistant Professor

Research and Development · India

WeGreened EB-2 (NIW) approved
North Carolina 121 days 2026-01-21
The petitioner proposes to investigate cardiac physiology in the context of heart failure using mouse models to facilitate successful therapeutic interventions for cardiovascular diseases. The work focuses on identifying therapeutic targets and evaluating pharmacological compounds and cell-derived products to improve treatment pathways. This research aims to provide actionable insights into how heart failure develops and progresses to support translational decision-making.
View Case

Physician

Healthcare

WeGreened EB-2 (NIW) approved
Pennsylvania 5 days 2025-07-21
The petitioner proposes to continue her research into regenerative gene therapy for advanced heart failure, focusing on uncovering molecular mechanisms and improving outcomes for patients with ischemic myocardial disease. Her work involves studying structural and functional changes in the myocardium under ischemic stress to develop methods for cardiac regeneration and survival.
View Case

Research Fellow

Healthcare · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 49 days 2025-06-12
The petitioner proposes to develop medications, tools, and techniques to mitigate the onset and progression of atherosclerosis and heart failure. His work involves original clinical studies and collaborative industry efforts to improve diagnostics and therapeutic strategies for cardiovascular care. The endeavor specifically targets catheter-device-related infections, diuretic resistance, and catastrophic antiphospholipid syndrome.
View Case

Physician

Healthcare · Brazil

WeGreened EB-2 (NIW) rfe approved
212 days 2025-12-24
The petitioner proposes to continue conducting clinical research leveraging extensive healthcare and literature databases to identify factors influencing cardiovascular outcomes in cancer survivors and patients with heart failure. This work aims to develop more effective prevention strategies and treatment decisions for patients facing elevated cardiovascular risks.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Greece

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 37 days
Criteria Met 3 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Greece All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist